Literature DB >> 15579502

Indomethacin enhances shuttling of aquaporin-2 despite decreased abundance in rat kidney.

Soo Wan Kim1, Joon Wan Kim, Ki Chul Choi, Seong Kwon Ma, Yoonwha Oh, Ju-Young Jung, Jin Kim, JongUn Lee.   

Abstract

The effect of nonsteroidal antiinflammatory drugs on the regulation of aquaporin-2 (AQP2) water channels in the kidney was determined. Male Sprague-Dawley rats were injected with indomethacin (5 mg/kg twice a day intraperitoneally) for 2 d. The control group was injected with vehicle. The expression of AQP2 proteins was determined in the kidney by immunoblotting and immunohistochemistry. The expression of G(salpha) and type VI adenylyl cyclase was determined by immunoblotting. The activity of adenylyl cyclase complexes was determined by stimulated accumulation of cAMP. Immunoblotting revealed that indomethacin markedly decreased the expression of AQP2. Accordingly, however, the ratio of AQP2 expression in the membrane fraction versus that in the cytoplasmic fraction was increased. The urinary excretion of AQP2 proteins also increased. Immunohistochemistry demonstrated almost exclusive apical labeling of AQP2 with scanty cytoplasmic localization along the collecting duct. The expression of G(salpha) and adenylyl cyclase VI proteins was decreased. The generation of cAMP provoked by arginine vasopressin, sodium fluoride, or forskolin was blunted. These results suggest that indomethacin increases the shuttling of AQP2 while it decreases its abundance in the collecting duct.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15579502     DOI: 10.1097/01.ASN.0000145877.28811.82

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  8 in total

1.  Simvastatin enhances aquaporin-2 surface expression and urinary concentration in vasopressin-deficient Brattleboro rats through modulation of Rho GTPase.

Authors:  Wei Li; Yan Zhang; Richard Bouley; Ying Chen; Toshiyuki Matsuzaki; Paula Nunes; Udo Hasler; Dennis Brown; Hua A Jenny Lu
Journal:  Am J Physiol Renal Physiol       Date:  2011-04-20

2.  The renal adverse effects of ibuprofen are not mediated by AQP2 water channels.

Authors:  Rachel Vieux; Marina Zelenina; Anita Aperia; Jean-Michel Hascoët
Journal:  Pediatr Nephrol       Date:  2010-07       Impact factor: 3.714

3.  Efficacy of COX-2 inhibitors in a case of congenital nephrogenic diabetes insipidus.

Authors:  Alper Soylu; Belde Kasap; Nilüfer Oğün; Yeşim Oztürk; Mehmet Türkmen; Lies Hoefsloot; Salih Kavukçu
Journal:  Pediatr Nephrol       Date:  2005-10-21       Impact factor: 3.714

Review 4.  The Trafficking of the Water Channel Aquaporin-2 in Renal Principal Cells-a Potential Target for Pharmacological Intervention in Cardiovascular Diseases.

Authors:  Tanja Vukićević; Maike Schulz; Dörte Faust; Enno Klussmann
Journal:  Front Pharmacol       Date:  2016-02-11       Impact factor: 5.810

5.  NSAIDs Alter Phosphorylated Forms of AQP2 in the Inner Medullary Tip.

Authors:  Huiwen Ren; Baoxue Yang; Patrick A Molina; Jeff M Sands; Janet D Klein
Journal:  PLoS One       Date:  2015-10-30       Impact factor: 3.240

Review 6.  A novel therapeutic effect of statins on nephrogenic diabetes insipidus.

Authors:  Leonilde Bonfrate; Giuseppe Procino; David Q-H Wang; Maria Svelto; Piero Portincasa
Journal:  J Cell Mol Med       Date:  2015-01-16       Impact factor: 5.310

7.  Increased renal sodium absorption by inhibition of prostaglandin synthesis during fasting in healthy man. A possible role of the epithelial sodium channels.

Authors:  Thomas G Lauridsen; Henrik Vase; Jørn Starklint; Carolina C Graffe; Jesper N Bech; Søren Nielsen; Erling B Pedersen
Journal:  BMC Nephrol       Date:  2010-10-28       Impact factor: 2.388

Review 8.  Nonsteroidal Anti-Inflammatory Drugs and the Kidney.

Authors:  Walter H Hörl
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.